NCT00608868View on ClinicalTrials.gov

SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG

Gefitinib

Gefitinib tablet 250mg once daily orally

Trial Locations (1)

Unknown

Research Site, Daegu

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY